Real-Time Magnetic Resonance Guided Focused Ultrasound for Painful Bone Metastases.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
05 03 2021
Historique:
entrez: 22 3 2021
pubmed: 23 3 2021
medline: 17 4 2021
Statut: epublish

Résumé

Bones are one of the most common sites of cancer metastasis, which usually causes pain and impairs quality of life. Radiation therapy combined with opioids is the standard treatment for painful bone metastases. This treatment achieves effective pain control in 60-74% of patients, but limited treatment choices with limited benefits are available for recurrent or residual painful bone metastases after radiotherapy. More than 40% of patients still experience moderate to severe bone pain after reirradiation. Magnetic resonance-guided focused ultrasound (MRgFUS) combines high-intensity focused ultrasound, which achieves thermal ablation of bone metastases and subsequent pain reduction, with real-time magnetic resonance (MR) thermometry to monitor the temperature of anatomic MR images, with an accuracy of 1 °C, spatial resolution of 1 mm, and temporal resolution within 3 s. As well as being increasingly used clinically for controlling metastatic bone pain, the use of MRgFUS for other diseases has also been tested. However, the use of MR software as a thermometer is the only technique available to verify the accuracy of the software and assure energy delivery. Here, we describe an efficient method of quality assurance we developed for thermal detection and energy delivery before each MRgFUS treatment and also propose a modified workflow to expedite the treatment course as well as to reduce patients' pain during the procedure.

Identifiants

pubmed: 33749680
doi: 10.3791/60615
doi:

Types de publication

Journal Article Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Wei-Jun Wang (WJ)

Department of Radiation Oncology, Taipei Medical University Hospital.

Hsin-Lun Lee (HL)

Department of Radiation Oncology, Taipei Medical University Hospital; The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei Medical University.

Shiu-Chen Jeng (SC)

Department of Radiation Oncology, Taipei Medical University Hospital; School of Dentistry, College of Oral Medicine, Taipei Medical University.

Jeng-Fong Chiou (JF)

Department of Radiation Oncology, Taipei Medical University Hospital; Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University; Taipei Cancer Center, Taipei Medical University.

Yaoru Huang (Y)

Department of Radiation Oncology, Taipei Medical University Hospital; Graduate Institute of Biomedical Materials & Tissue Engineering, College of Biomedical Engineering, Taipei Medical University; ruiseart.huang@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH